Insight Molecular Diagnostics Inc. Common Stock IMDX
$3.44
-0.86%
at last close
Analyst Consensus
- Consensus Rating
- Buy (3 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $9.67
- Implied Upside
- +181.0%
- Price Target Range
- $8.00 – $12.00
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-24 | LUCID CAPITAL MARKETSAlex Nowark |
Initiates coverage on | Buy | $8 |
| 2026-08-18 | NeedhamMike Matson |
Reiterates | Buy | $9 |
| 2026-02-17 | Lake StreetThomas Flaten |
Maintains | Buy | $8 → $12 |
| 2025-11-11 | NeedhamMike Matson |
Maintains | Buy | $4 → $9 |
| 2025-08-18 | NeedhamMike Matson |
Reiterates | Buy | $4 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $3.44
- Market Cap
- $113.55 million
- 52-Week Range
- $2.33 – $8.51
- Average Volume
- 241K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.